US FDA and University of Rochester partner for new drug products
The U.S. Food and Drug Administration recently selected the University of Rochester Medical Center to lead a new initiative to accelerate the identification of improved pain treatments. The partnership, known as Analgesic Clinical Trial Innovations, Opportunities, and Networks, will analyze a wide range of clinical trials of treatments for acute and chronic pain, looking specifically at the approach and procedures used in each trial. Researchers hope to identify problems or gaps in trial design and implementation, and find ways to bridge these gaps to speed the development of new safe and effective medications.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063